missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ TAT complex Monoclonal Antibody (C1), Invitrogen™
GREENER_CHOICE

Mouse Monoclonal Antibody

Brand:  Invitrogen™ MA551121

 View more versions of this product

Product Code. 17958622

  • £626.00 / 200µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

The Thrombin-antithrombin complex (TAT complex) is a protein complex formed by the binding of thrombin, a serine protease involved in blood clotting, and antithrombin, a serine protease inhibitor that regulates thrombin activity. This complex plays a crucial role in maintaining the balance between blood clotting and preventing excessive clotting, which can lead to thrombosis. The complex is formed when antithrombin binds to thrombin, inhibiting its activity and preventing the formation of blood clots.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TAT complex
Monoclonal
1 mg/mL
PBS with 50% glycerol and 0.05% Proclin 300; pH 7.4
P00734, P01008
F2, SERPINC1
Recombinant Human TAT protein, Ile364-Glu622 + GGGGS*3 + His33-Lys464 (Accession #P00734 & P01008).
200 μL
Primary
Human
Antibody
IgG1 κ
Western Blot
C1
Unconjugated
SERPINC1
TAT
Mouse
Protein A/G
RUO
2147, 462
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.